ACB
Aurora Cannabis Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$3.95
+1.54%Sep 2, 2026, 17:26 UTC
Aurora Cannabis's board rejected an acquisition offer from Curaleaf.
Aug 19, 2026, 18:00 UTC
Aurora Cannabis acquired Internode Pharma Limited and HAP Pharma Limited to expand its distribution access to the UK medical cannabis market.
Source:Aug 19, 2026, 12:11 UTC
Aurora Cannabis confirms a hostile takeover bid for Curaleaf.
Source:Aug 11, 2026, 13:05 UTC
Curaleaf announced it will make a takeover offer for Aurora Cannabis, causing Aurora's stock to jump.
Aug 5, 2026, 14:57 UTC
Aurora Cannabis Inc. reported quarterly earnings of $0.04 per share for the quarter ended June 2026, beating the Zacks Consensus Estimate of a loss of $0.13 per share.
Source:Jul 23, 2026, 17:15 UTC
Safari Flower Company, a subsidiary of Aurora Cannabis Inc., received EU-GMP certification for its Niagara facility in Ontario, Canada.
Source:Jun 11, 2026, 13:05 UTC
Aurora Cannabis Inc. announced its financial and operational results for the fourth quarter and fiscal year 2026, reporting record annual global medical cannabis net revenue of $288.6 million and record annual adjusted EBITDA of $53.8 million.
Source:Jun 11, 2026, 13:05 UTC
Aurora Cannabis Inc. completed the accretive acquisition of Safari Flower Company in April 2026.
Source: